Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 145 participants.
Also called NCT07250763
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 145 participants
- Sponsor
- Registry
-
NCT07250763
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07250763. Allocation not applicable; no masking; primary purpose treatment. Start 2023-09-20 (actual); primary completion 2027-02-28 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
- Condition
- Pulmonary Embolism
- Condition
- Deep Vein Thrombosis
- Condition
- Atrial Fibrillation
- Condition
- Acute Cardiac Syndrome
- Condition
- Mechanical Heart Valve Recipients
- Intervention (Drug)
- Initial Heparin Dose Modification
- Lead sponsor
- Inova Health Care Services
Record details
- Record id
cardio:ct-nct07250763- Content hash
44a17c564b35b26ef06545fcf47f16b8d59206c88b2153a12fe935cb4eb54605